REG - Societe Generale SA Takeda Pharma.Co.Ltd - Form 8.3 - Takeda Pharmaceutical CO LTD
RNS Number : 5030MSociete Generale SA08 January 2019FORM 8.3
PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY
A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE
Rule 8.3 of the Takeover Code (the "Code")
1. KEY INFORMATION
(a) Full name of discloser:
Société Générale S.A.
(b) Owner or controller of interests and short positions disclosed, if different from 1(a):
The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named.
(c) Name of offeror/offeree in relation to whose relevant securities this form relates:
Use a separate form for each offeror/offeree
Takeda Pharmaceutical CO LTD
(d) If an exempt fund manager connected with an offeror/offeree, state this and specify identity of offeror/offeree:
(e) Date position held/dealing undertaken:
For an opening position disclosure, state the latest practicable date prior to the disclosure
07/01/2019
(f) In addition to the company in 1(c) above, is the discloser making disclosures in respect of any other party to the offer?
If it is a cash offer or possible cash offer, state "N/A"
YES: Shire PLC
2. POSITIONS OF THE PERSON MAKING THE DISCLOSURE
If there are positions or rights to subscribe to disclose in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 2(a) or (b) (as appropriate) for each additional class of relevant security.
(a) Interests and short positions in the relevant securities of the offeror or offeree to which the disclosure relates following the dealing (if any)
Class of relevant security:
Ordinary
Interests
Short positions
Number
%
Number
%
(1) Relevant securities owned and/or controlled:
1,698,734
0.22
17,039,212
2.17
(2) Cash-settled derivatives:
16,189,760
2.06
0
0.00
(3) Stock-settled derivatives (including options) and agreements to purchase/sell:
0
0.00
425,000
0.05
TOTAL:
17,888,494
2.28
17,464,212
2.23
All interests and all short positions should be disclosed.
Details of any open stock-settled derivative positions (including traded options), or agreements to purchase or sell relevant securities, should be given on a Supplemental Form 8 (Open Positions).
(b) Rights to subscribe for new securities (including directors' and other employee options)
Class of relevant security in relation to which subscription right exists:
Details, including nature of the rights concerned and relevant percentages:
3. DEALINGS (IF ANY) BY THE PERSON MAKING THE DISCLOSURE
Where there have been dealings in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 3(a), (b), (c) or (d) (as appropriate) for each additional class of relevant security dealt in.
The currency of all prices and other monetary amounts should be stated.
(a) Purchases and sales
Class of relevant security
Purchase/sale
Number of securities
Price per unit JPY
Ordinary
Purchase
41,100
4003.101808
Ordinary
Purchase
100
4037
Ordinary
Purchase
100
4028
Ordinary
Purchase
100
4010
Ordinary
Purchase
100
3960
Ordinary
Purchase
100
4030
Ordinary
Purchase
100
4023
Ordinary
Purchase
100
3983
Ordinary
Purchase
100
3980
Ordinary
Purchase
100
3968
Ordinary
Purchase
200
3974
Ordinary
Purchase
100
3922
Ordinary
Purchase
100
3979
Ordinary
Purchase
100
3914
Ordinary
Purchase
100
3913
Ordinary
Purchase
200
3912
Ordinary
Purchase
200
3953
Ordinary
Purchase
100
3965
Ordinary
Purchase
200
3971
Ordinary
Purchase
100
3997
Ordinary
Purchase
200
3974
Ordinary
Purchase
100
3945
Ordinary
Purchase
100
3911
Ordinary
Purchase
100
3924
Ordinary
Purchase
100
4046
Ordinary
Purchase
100
3944
Ordinary
Purchase
100
3914
Ordinary
Purchase
100
3969
Ordinary
Purchase
100
3970
Ordinary
Purchase
100
3969
Ordinary
Purchase
200
4034
Ordinary
Purchase
100
4029
Ordinary
Purchase
200
3923
Ordinary
Purchase
100
3914
Ordinary
Purchase
100
3985
Ordinary
Purchase
100
3914
Ordinary
Purchase
100
4027
Ordinary
Purchase
100
3913
Ordinary
Purchase
100
3926
Ordinary
Purchase
100
3930
Ordinary
Purchase
100
3913
Ordinary
Purchase
100
3977
Ordinary
Purchase
100
4045
Ordinary
Purchase
100
4044
Ordinary
Purchase
100
3973
Ordinary
Purchase
100
3973
Ordinary
Purchase
100
3969
Ordinary
Purchase
200
3978
Ordinary
Purchase
100
3969
Ordinary
Purchase
300
3987
Ordinary
Purchase
300
4021
Ordinary
Purchase
300
4020
Ordinary
Purchase
200
3964
Ordinary
Purchase
300
3920
Ordinary
Purchase
300
3919
Ordinary
Purchase
300
3922
Ordinary
Purchase
300
3921
Ordinary
Purchase
300
3922
Ordinary
Purchase
300
3997
Ordinary
Purchase
100
4058
Ordinary
Purchase
300
3912
Ordinary
Purchase
300
3913
Ordinary
Purchase
400
3911
Ordinary
Purchase
300
3910
Ordinary
Purchase
300
3911
Ordinary
Purchase
400
4036
Ordinary
Purchase
100
4021
Ordinary
Purchase
100
4040
Ordinary
Purchase
300
4035
Ordinary
Purchase
200
4037
Ordinary
Purchase
300
3974
Ordinary
Purchase
200
3969
Ordinary
Purchase
300
4038
Ordinary
Purchase
300
3972
Ordinary
Purchase
100
3984
Ordinary
Purchase
200
3993
Ordinary
Purchase
200
3977
Ordinary
Purchase
400
3981
Ordinary
Purchase
100
4028
Ordinary
Purchase
100
3992
Ordinary
Purchase
400
3980
Ordinary
Purchase
100
3994
Ordinary
Purchase
100
3976
Ordinary
Purchase
100
3982
Ordinary
Purchase
100
3994
Ordinary
Purchase
100
3984
Ordinary
Purchase
200
3976
Ordinary
Purchase
100
3989
Ordinary
Purchase
100
3980
Ordinary
Purchase
100
3988
Ordinary
Purchase
200
4011
Ordinary
Purchase
200
3992
Ordinary
Purchase
100
3994
Ordinary
Purchase
200
3990
Ordinary
Purchase
100
3990
Ordinary
Purchase
200
3993
Ordinary
Purchase
100
3980
Ordinary
Purchase
400
3979
Ordinary
Purchase
200
3995
Ordinary
Purchase
100
3995
Ordinary
Purchase
100
3996
Ordinary
Purchase
100
3912
Ordinary
Purchase
100
3977
Ordinary
Purchase
100
3995
Ordinary
Purchase
200
3977
Ordinary
Purchase
100
3980
Ordinary
Purchase
100
3997
Ordinary
Purchase
200
3911
Ordinary
Purchase
100
3995
Ordinary
Purchase
100
3995
Ordinary
Purchase
200
3986
Ordinary
Purchase
200
3993
Ordinary
Purchase
100
3983
Ordinary
Purchase
100
3993
Ordinary
Purchase
100
3975
Ordinary
Purchase
200
3990
Ordinary
Purchase
100
3991
Ordinary
Purchase
100
3994
Ordinary
Purchase
100
3993
Ordinary
Purchase
100
3980
Ordinary
Purchase
100
3983
Ordinary
Purchase
100
3984
Ordinary
Purchase
100
3984
Ordinary
Purchase
200
3994
Ordinary
Purchase
100
3993
Ordinary
Purchase
100
3985
Ordinary
Purchase
200
3994
Ordinary
Purchase
200
3985
Ordinary
Purchase
200
3996
Ordinary
Purchase
200
3992
Ordinary
Purchase
100
3981
Ordinary
Purchase
100
3985
Ordinary
Purchase
100
3986
Ordinary
Purchase
100
3989
Ordinary
Purchase
100
3957
Ordinary
Purchase
200
3983
Ordinary
Purchase
200
3980
Ordinary
Purchase
200
3990
Ordinary
Purchase
200
3986
Ordinary
Purchase
600
3978
Ordinary
Purchase
100
3975
Ordinary
Purchase
100
3974
Ordinary
Purchase
100
3992
Ordinary
Purchase
200
3994
Ordinary
Purchase
200
3975
Ordinary
Purchase
100
3994
Ordinary
Purchase
100
3994
Ordinary
Purchase
100
3990
Ordinary
Sale
100
3960
Ordinary
Sale
100
4036.5
Ordinary
Sale
100
3960
Ordinary
Sale
300
3960
Ordinary
Sale
100
3960
Ordinary
Sale
3,100
3975
Ordinary
Sale
100
3960
Ordinary
Sale
100
3960
Ordinary
Sale
300
3960
Ordinary
Sale
200
3960
Ordinary
Sale
1,900
3975
Ordinary
Sale
3,700
3960
Ordinary
Sale
100
3975
Ordinary
Sale
200
3975
Ordinary
Sale
100
3960
Ordinary
Sale
3,000
3970
Ordinary
Sale
100
3975
Ordinary
Sale
2,600
3975
Ordinary
Sale
100
3975
Ordinary
Sale
100
3975
Ordinary
Sale
100
3975
Ordinary
Sale
200
3975
Ordinary
Sale
100
3975
Ordinary
Sale
100
3970
Ordinary
Sale
100
3975
Ordinary
Sale
100
3975
Ordinary
Sale
100
3975
Ordinary
Sale
300
3975
Ordinary
Sale
300
3975
Ordinary
Sale
100
3975
Ordinary
Sale
100
3975
Ordinary
Sale
100
3975
Ordinary
Sale
300
3970
Ordinary
Sale
100
3970
Ordinary
Sale
100
4030
Ordinary
Sale
100
4030
Ordinary
Sale
100
4030
Ordinary
Sale
100
4030
Ordinary
Sale
100
4030
Ordinary
Sale
100
3975
Ordinary
Sale
100
3970
Ordinary
Sale
1,400
3970
Ordinary
Sale
100
4033
Ordinary
Sale
100
4030
Ordinary
Sale
100
4030
Ordinary
Sale
200
4033
Ordinary
Sale
100
4030
Ordinary
Sale
100
4033
Ordinary
Sale
100
4030
Ordinary
Sale
4,200
4033
Ordinary
Sale
100
4030
Ordinary
Sale
100
4030
Ordinary
Sale
1,000
4030
Ordinary
Sale
100
4030
Ordinary
Sale
400
4033
Ordinary
Sale
100
4030
Ordinary
Sale
100
4030
Ordinary
Sale
100
4030
Ordinary
Sale
200
4030
Ordinary
Sale
200
4030
Ordinary
Sale
100
3911
Ordinary
Sale
62,700
3995
Ordinary
Sale
62,700
3995
Ordinary
Sale
62,700
3995
Ordinary
Sale
63,100
3995
Ordinary
Sale
62,700
3995
Ordinary
Sale
100
4031
Ordinary
Sale
900
4044
Ordinary
Sale
500
4038
Ordinary
Sale
100
4041
Ordinary
Sale
200
4043
Ordinary
Sale
100
4044
Ordinary
Sale
100
4046
Ordinary
Sale
100
4052
Ordinary
Sale
600
4056
Ordinary
Sale
100
3989
Ordinary
Sale
100
4072
Ordinary
Sale
500
3995
Ordinary
Sale
100
3994
Ordinary
Sale
100
3992
Ordinary
Sale
100
3975
Ordinary
Sale
100
3936
Ordinary
Sale
100
3915
Ordinary
Sale
100
3971
Ordinary
Sale
45,700
3995
Ordinary
Sale
300
3977
Ordinary
Sale
100
3979
Ordinary
Sale
100
3991
Ordinary
Sale
600
4030
Ordinary
Sale
100
4045
Ordinary
Sale
500
4045
Ordinary
Sale
600
3979
Ordinary
Sale
100
3971
Ordinary
Sale
100
3971
Ordinary
Sale
400
4046
Ordinary
Sale
100
4046
Ordinary
Sale
300
4050
Ordinary
Sale
300
4050
Ordinary
Sale
100
4063
Ordinary
Sale
500
4061
Ordinary
Sale
100
4082
Ordinary
Sale
300
4082
Ordinary
Sale
100
3959
Ordinary
Sale
200
3960
Ordinary
Sale
200
3908
Ordinary
Sale
100
3908
Ordinary
Sale
1,100
4002
Ordinary
Sale
100
3966
Ordinary
Sale
100
4052
Ordinary
Sale
100
3925
Ordinary
Sale
100
3909
Ordinary
Sale
100
4045
Ordinary
Sale
100
3976
Ordinary
Sale
100
3911
Ordinary
Sale
100
3979
Ordinary
Sale
200
3975
Ordinary
Sale
200
4035
Ordinary
Sale
100
3925
Ordinary
Sale
200
3954
Ordinary
Sale
200
3922
Ordinary
Sale
100
3951
Ordinary
Sale
100
3908
Ordinary
Sale
100
3983
Ordinary
Sale
100
3982
Ordinary
Sale
100
3985
Ordinary
Sale
200
3970
Ordinary
Sale
200
3973
Ordinary
Sale
200
3971
Ordinary
Sale
100
3981.1
Ordinary
Sale
100
3979.5
Ordinary
Sale
100
3982
Ordinary
Sale
100
3988
Ordinary
Sale
100
3950
Ordinary
Sale
100
3976
Ordinary
Sale
100
3973
Ordinary
Sale
100
3978
Ordinary
Sale
100
3940
Ordinary
Sale
100
3983
Ordinary
Sale
100
3985
Ordinary
Sale
100
3973
Ordinary
Sale
500
3992
Ordinary
Sale
100
3977
Ordinary
Sale
100
3980
Ordinary
Sale
100
3944
Ordinary
Sale
100
3991
Ordinary
Sale
100
3993
Ordinary
Sale
100
3995
Ordinary
Sale
100
3945
Ordinary
Sale
100
3993
Ordinary
Sale
100
3990
Ordinary
Sale
100
3968
Ordinary
Sale
100
3908
Ordinary
Sale
100
3954
Ordinary
Sale
100
4080
Ordinary
Sale
100
4082
Ordinary
Sale
100
3983
Ordinary
Sale
100
3988
Ordinary
Sale
100
3994
Ordinary
Sale
100
3988
Ordinary
Sale
100
3922
Ordinary
Sale
100
3925
Ordinary
Sale
100
3913
Ordinary
Sale
100
3914
Ordinary
Sale
100
3973
Ordinary
Sale
100
3976
Ordinary
Sale
100
3955
Ordinary
Sale
100
3924
Ordinary
Sale
100
3982
Ordinary
Sale
100
3976
Ordinary
Sale
100
3970
Ordinary
Sale
100
3970
Ordinary
Sale
100
4042
Ordinary
Sale
2,200
3995
Ordinary
Sale
100
3975
Ordinary
Sale
2,100
4030
Ordinary
Sale
32
3705
Total Purchases
64,700
Total Sales
410,032
(b) Cash-settled derivative transactions
Class of relevant security
Product description
e.g. CFD
Nature of dealing
e.g. opening/closing a long/short position, increasing/reducing a long/short position
Number of reference securities
Price per unit JPY
(c) Stock-settled derivative transactions (including options)
(i) Writing, selling, purchasing or varying
Class of relevant security
Product description e.g. call option
Writing, purchasing, selling, varying etc.
Number of securities to which option relates
Exercise price per unit
Type
e.g. American, European etc.
Expiry date
Option money paid/ received per unit USD
ADS
Listed call-option
Selling
200,000
15
American
18/01/2019
3.5
ADS
Listed call-option
Selling
100,000
15
American
18/01/2019
3.6
(ii) Exercise
Class of relevant security
Product description
e.g. call option
Exercising/ exercised against
Number of securities
Exercise price per unit JPY
(d) Other dealings (including subscribing for new securities)
Class of relevant security
Nature of dealing
e.g. subscription, conversion
Details
Price per unit (if applicable) JPY
4. OTHER INFORMATION
(a) Indemnity and other dealing arrangements
Details of any indemnity or option arrangement, or any agreement or understanding, formal or informal, relating to relevant securities which may be an inducement to deal or refrain from dealing entered into by the person making the disclosure and any party to the offer or any person acting in concert with a party to the offer:
Irrevocable commitments and letters of intent should not be included. If there are no such agreements, arrangements or understandings, state "none"
(b) Agreements, arrangements or understandings relating to options or derivatives
Details of any agreement, arrangement or understanding, formal or informal, between the person making the disclosure and any other person relating to:
(i) the voting rights of any relevant securities under any option; or
(ii) the voting rights or future acquisition or disposal of any relevant securities to which any derivative is referenced:
If there are no such agreements, arrangements or understandings, state "none"
(c) Attachments
Is a Supplemental Form 8 (Open Positions) attached?
YES
Date of disclosure:
08/01/2019
Contact name:
Olivier Vero
Telephone number:
+44 20 7676 6969
Public disclosures under Rule 8 of the Code must be made to a Regulatory Information Service.
The Panel's Market Surveillance Unit is available for consultation in relation to the Code's disclosure requirements on +44 (0)20 7638 0129.The Code can be viewed on the Panel's website at www.thetakeoverpanel.org.uk
SUPPLEMENTAL FORM 8 (OPEN POSITIONS)
DETAILS OF OPEN STOCK-SETTLED DERIVATIVE (INCLUDING OPTION) POSITIONS, AGREEMENTS TO PURCHASE OR SELL ETC.
Note 5(i) on Rule 8 of the Takeover Code (the "Code")
1. KEY INFORMATION
Full name of person making disclosure:
SOCIETE GENERALE SA
Name of offeror/offeree in relation to whose relevant securities the disclosure relates:
Takeda Pharmaceutical CO LTD
2. STOCK-SETTLED DERIVATIVES (INCLUDING OPTIONS)
Class of relevant security
Product description e.g. call option
Written or purchased
Number of securities to which option or derivative relates
Exercise price per unit
Type
Expiry date
JPY
e.g. American, European etc.
Ordinary
Listed call-option
Sale
125,000
5,500
European options
13/06/2019
Class of relevant security
Product description e.g. call option
Written or purchased
Number of securities to which option or derivative relates
Exercise price per unit
USD
Type
e.g. American, European etc.
Expiry date
ADS
Listed call-option
Sale
300,000
15
American options
18/01/2019
3. AGREEMENTS TO PURCHASE OR SELL ETC.
Full details should be given so that the nature of the interest or position can be fully understood:
It is not necessary to provide details on a Supplemental Form (Open Positions) with regard to cash-settled derivatives.
The currency of all prices and other monetary amounts should be stated.
The Panel's Market Surveillance Unit is available for consultation in relation to the Code's disclosure requirements on +44 (0)20 7638 0129.
The Code can be viewed on the Panel's website at www.thetakeoverpanel.org.uk.
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.ENDRETUGUACGUPBUBR
Recent news on Takeda Pharmaceutical Co
See all newsREG - Malin Corp PLC - Malin Announces 2021 Full Year Results
AnnouncementREG - Takeda Pharma.Co.Ltd Shire plc - Confirmation of post-offer intention statements
AnnouncementREG - Morgan Stanley&CoLLC Takeda Pharma.Co.Ltd - Form 8.5 (EPT/RI) - Replacement of Takeda
AnnouncementREG - Takeda Pharma.Co.Ltd Shire plc - Statement re Applicable Exchange Rate
AnnouncementREG - Morgan Stanley Takeda Pharma.Co.Ltd - Form 8.5 (EPT/NON-RI) - Replacement of Takeda
Announcement